Skip to main content
. 2016 Mar 24;48(4):1399–1407. doi: 10.4143/crt.2015.481

Table 4.

Multivariate analysis of factors affecting PFS and OS in high-risk patients

Risk factor PFS
OS
HR 95% CI p-value HR 95% CI p-value
Age ≥ 12 mo 0.56 0.12-2.62 0.458 0.27 0.07-1.11 0.069
Unfavorable pathology 1.35 0.47-3.89 0.582 2.98 0.75-11.88 0.122
MYCN amplification 0.97 0.37-2.55 0.949 1.84 0.75-4.50 0.181
PB TH-positive at diagnosis 9.02 2.06-39.50 0.004 3.54 1.26-9.93 0.016

PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; PB, peripheral blood; TH, tyrosine hydroxylase.